Effects of once-weekly semaglutide vs once-daily canagliflozin on body composition in type 2 diabetes: a substudy of the SUSTAIN 8 randomised controlled clinical trial

被引：0
|
作者：
Rory J. McCrimmon
Andrei-Mircea Catarig
Juan P. Frias
Nanna L. Lausvig
Carel W. le Roux
Desirée Thielke
Ildiko Lingvay
机构：
[1] School of Medicine,Diabetes Complications Research Centre
[2] University of Dundee,Department of Internal Medicine
[3] Ninewells Hospital and Medical School,undefined
[4] Novo Nordisk A/S,undefined
[5] National Research Institute,undefined
[6] University College Dublin,undefined
[7] UT Southwestern Medical Center,undefined
来源：
Diabetologia | 2020年 / 63卷
关键词：
Body composition; Canagliflozin; Fat mass; Glucagon-like peptide receptor agonists; Randomised controlled trial; Semaglutide; Type 2 diabetes; Weight;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：473 / 485
页数：12
相关论文
共 50 条
  • [1] Effects of once-weekly semaglutide vs once-daily canagliflozin on body composition in type 2 diabetes: a substudy of the SUSTAIN 8 randomised controlled clinical trial
    McCrimmon, Rory J.
    Catarig, Andrei-Mircea
    Frias, Juan P.
    Lausvig, Nanna L.
    le Roux, Carel W.
    Thielke, Desiree
    Lingvay, Ildiko
    [J]. DIABETOLOGIA, 2020, 63 (03) : 473 - 485
  • [2] Effects of once-weekly semaglutide vs canagliflozin on body composition in type 2 diabetes: a substudy of the SUSTAIN 8 trial
    McCrimmon, R. J.
    Catarig, A.
    Frias, J. P.
    Lausvig, N. L.
    le Roux, C. W.
    Thielke, D.
    Lingvay, I.
    [J]. DIABETOLOGIA, 2019, 62 : S29 - S29
  • [3] Once-weekly semaglutide vs canagliflozin in type 2 diabetes: results of the SUSTAIN 8 trial
    Lingvay, I.
    Catarig, A.
    Frias, J. P.
    Kumar, H.
    Lausvig, N. L.
    le Roux, C. W.
    Thielke, D.
    Viljoen, A.
    McCrimmon, R. J.
    [J]. DIABETOLOGIA, 2019, 62 : S27 - S28
  • [4] Efficacy and safety of once-weekly semaglutide vs once-daily insulin glargine in insulin-naive subjects with Type 2 diabetes (SUSTAIN 4)
    Aroda, V. R.
    Bain, S. C.
    Cariou, B.
    Piletic, M.
    Rose, L.
    Axelsen, M.
    Rowe, E.
    de Vries, J. H.
    [J]. DIABETIC MEDICINE, 2017, 34 : 146 - 146
  • [5] Efficacy and safety of once-weekly semaglutide vs once-daily insulin glargine in insulin-naive subjects with type 2 diabetes (SUSTAIN 4)
    DeVries, J. H.
    Bain, S. C.
    Cariou, B.
    Rose, L.
    Axelsen, M.
    Rowe, E.
    Aroda, V. R.
    [J]. DIABETOLOGIA, 2016, 59 : S76 - S77
  • [6] Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine in insulin-naive subjects with type 2 diabetes (SUSTAIN 4)
    Aroda, Vanita
    Bain, Stephen
    Cariou, Bertrand
    Piletic, Milivoj
    Rose, Ludger
    Bergan, Eirik Quamme
    Zacho, Jeppe
    Devries, J. Hans
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S51 - S51
  • [7] Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial
    Lingvay, Ildiko
    Catarig, Andrei-Mircea
    Frias, Juan P.
    Kumar, Harish
    Lausvig, Nanna L.
    le Roux, Caret W.
    Thielke, Desiree
    Viljoen, Adie
    McCrimmon, Rory J.
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (11): : 834 - 844
  • [8] Efficacy and safety of once-weekly semaglutide monotherapy vs placebo in subjects with Type 2 diabetes (SUSTAIN 1)
    Sorli, C.
    Harashima, S-I
    Tsoukas, G.
    Unger, J.
    Karsbol, J. D.
    Bain, S.
    [J]. DIABETIC MEDICINE, 2017, 34 : 145 - 145
  • [9] Efficacy and Safety of Once-Weekly Dulaglutide vs. Once-Daily Liraglutide in Japanese Patients with Type 2 Diabetes
    Takamura, Toshinari
    Miyagawa, Jun-Ichiro
    Odawara, Masato
    Takita, Yasushi
    Iwamoto, Noriyuki
    Imaoka, Takeshi
    [J]. DIABETES, 2015, 64 : A285 - A285
  • [10] Efficacy and Safety of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin as Metformin Add-on in a Korean Population with Type 2 Diabetes
    Lee, Byung-Wan
    Cho, Young Min
    Kim, Sin Gon
    Ko, Seung-Hyun
    Lim, Soo
    Dahaoui, Amine
    Jeong, Jin Sook
    Lim, Hyo Jin
    Yu, Jae Myung
    [J]. DIABETES THERAPY, 2024, 15 (02) : 547 - 563
12345